X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global Expression Vectors Companies

This report lists the top Global Expression Vectors companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Expression Vectors industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Global Expression Vectors Top Companies

  1. Thermo Fisher Scientific

  2. Promega

  3. Merck

  4. Agilent Technologies

  5. Bio-Rad Laboratories

*Disclaimer: Top companies sorted in no particular order

Global Expression Vectors Market Major Players

Global Expression Vectors Market Concentration

Global Expression Vectors  Market Concentration

Global Expression Vectors Company List

                              • Thermo Fisher Scientific, Inc.

                              • Promega Corporation

                              • Sigma-Aldrich Corporation

                              • Bio-Rad Laboratories

                              • Agilent Technologies

                              • New England Biolabs

                              • Merck KGaA

                              • QIAGEN

                              • DNA2.0

                              • GenScript USA Inc.

                              • System Biosciences, LLC.

                              • TAKARA HOLDINGS Inc.

                              • OriGene Technologies, Inc.


                          Specific to Global Expression Vectors Market
                          Need More Details On Market Players And Competitors?
                          Download PDF

                          Expression Vectors Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)